Fidelity Investments’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$159M Buy
282,976
+31,569
+13% +$20.2M 0.01% 970
2025
Q4
$170M Buy
251,407
+18,361
+8% +$12.5M 0.01% 939
2025
Q3
$149M Sell
233,046
-36,836
-14% -$22.4M 0.01% 993
2025
Q2
$145M Buy
269,882
+15,918
+6% +$7.61M 0.01% 955
2025
Q1
$107M Sell
253,964
-32,935
-11% -$14.3M 0.01% 1070
2024
Q4
$119M Sell
286,899
-3,962
-1% -$1.74M 0.01% 1044
2024
Q3
$147M Buy
290,861
+10,017
+4% +$4.87M 0.01% 937
2024
Q2
$137M Sell
280,844
-87,565
-24% -$44M 0.01% 923
2024
Q1
$199M Buy
368,409
+42,123
+13% +$23M 0.01% 788
2023
Q4
$181M Buy
326,286
+10,689
+3% +$5.02M 0.01% 783
2023
Q3
$138M Buy
315,597
+6,927
+2% +$3.45M 0.01% 842
2023
Q2
$155M Sell
308,670
-12,107
-4% -$5.8M 0.01% 821
2023
Q1
$160M Sell
320,777
-953,387
-75% -$456M 0.01% 802
2022
Q4
$520M Sell
1,274,164
-329,360
-21% -$128M 0.05% 371
2022
Q3
$522M Sell
1,603,524
-464,290
-22% -$171M 0.05% 342
2022
Q2
$725M Buy
2,067,814
+934,829
+83% +$381M 0.07% 259
2022
Q1
$620M Buy
1,132,985
+122,127
+12% +$64.2M 0.05% 371
2021
Q4
$666M Buy
1,010,858
+45,980
+5% +$28.9M 0.05% 349
2021
Q3
$600M Buy
964,878
+23,404
+2% +$15.7M 0.05% 372
2021
Q2
$595M Buy
941,474
+28,742
+3% +$15.9M 0.05% 377
2021
Q1
$447M Buy
912,732
+652,345
+251% +$327M 0.04% 462
2020
Q4
$130M Buy
260,387
+23,795
+10% +$10.6M 0.01% 926
2020
Q3
$93M Sell
236,592
-585,869
-71% -$217M 0.01% 940
2020
Q2
$272M Sell
822,461
-175,742
-18% -$50.9M 0.03% 485
2020
Q1
$242M Buy
998,203
+749,438
+301% +$196M 0.03% 438
2019
Q4
$65M Sell
248,765
-672,105
-73% -$177M 0.01% 1093
2019
Q3
$250M Buy
920,870
+376,909
+69% +$105M 0.03% 550
2019
Q2
$150M Buy
543,961
+107,351
+25% +$26.5M 0.02% 755
2019
Q1
$97.6M Sell
436,610
-124,656
-22% -$25.7M 0.01% 915
2018
Q4
$104M Buy
561,266
+306,919
+121% +$62.9M 0.01% 831
2018
Q3
$63.5M Buy
254,347
+92,181
+57% +$22.4M 0.01% 1148
2018
Q2
$35.3M Sell
162,166
-76,854
-32% -$15.8M ﹤0.01% 1452
2018
Q1
$45.7M Buy
239,020
+224,929
+1,596% +$41.5M 0.01% 1335
2017
Q4
$2.2M Sell
14,091
-20,387
-59% -$3.21M ﹤0.01% 2337
2017
Q3
$5.36M Sell
34,478
-2,875
-8% -$455K ﹤0.01% 2138
2017
Q2
$6.03M Buy
37,353
+934
+3% +$152K ﹤0.01% 2116
2017
Q1
$5.63M Buy
36,419
+33,805
+1,293% +$4.66M ﹤0.01% 2149
2016
Q4
$307K Sell
2,614
-402,354
-99% -$45.9M ﹤0.01% 2582
2016
Q3
$45.7M Sell
404,968
-800
-0.2% -$84.3K 0.01% 1337
2016
Q2
$37.7M Buy
405,768
+192
+0% +$16.5K 0.01% 1397
2016
Q1
$31.8M Sell
405,576
-8,216
-2% -$592K ﹤0.01% 1446
2015
Q4
$30.2M Sell
413,792
-15,088
-4% -$1.08M ﹤0.01% 1476
2015
Q3
$31.8M Buy
428,880
+3,676
+0.9% +$263K ﹤0.01% 1450
2015
Q2
$27.3M Sell
425,204
-379,906
-47% -$26.3M ﹤0.01% 1610
2015
Q1
$62.2M Buy
805,110
+191,146
+31% +$14.9M 0.01% 1246
2014
Q4
$45.5M Buy
613,964
+161,298
+36% +$11.3M 0.01% 1366
2014
Q3
$26.7M Buy
452,666
+444,840
+5,684% +$28.1M ﹤0.01% 1613
2014
Q2
$523K Sell
7,826
-348,678
-98% -$22.2M ﹤0.01% 2591
2014
Q1
$21.6M Buy
356,504
+214,284
+151% +$12.8M ﹤0.01% 1712
2013
Q4
$7.56M Buy
142,220
+58,600
+70% +$3.08M ﹤0.01% 2059
2013
Q3
$4.17M Sell
83,620
-369,972
-82% -$17.8M ﹤0.01% 2205
2013
Q2
$20.4M Buy
+453,592
New +$19.8M ﹤0.01% 1658

Other funds holding IDXX

Fidelity Investments's IDXX Position: Q1 2026 in Review

Fidelity Investments increased its Idexx Laboratories (IDXX) stake by 13% in Q1 2026, buying an estimated $20.2M and bringing the position to 282,976 shares worth $159M. The position accounts for 0.01% of the portfolio, ranked #970.

Fidelity Investments first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $725M in Q2 2022. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Fidelity Investments held 282,976 shares of Idexx Laboratories worth $159M as of Q1 2026.
  • Fidelity Investments bought 31,569 Idexx Laboratories shares in Q1 2026, an estimated $20.2M.
  • Idexx Laboratories made up 0.01% of Fidelity Investments's portfolio in Q1 2026, its #970 holding.
  • Fidelity Investments first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Fidelity Investments's Idexx Laboratories position peaked at $725M in Q2 2022.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.